scPharmaceuticals

IRS: 465184075
SCPH

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Founded
2014 (9 years)
Investor RelationsSEC
Revenue
0 (2022)

Want to see more? Sign up!